Read the latest positive news, breakthroughs, and inspiring stories about liver disease, curated daily by BrightWire.
Millions of Americans living with chronic Hepatitis B now have a new treatment option after FDA approval. Bepirovirsen offers hope for patients seeking alternatives to manage this challenging liver condition.
A breakthrough treatment just succeeded in treating intense itching for children with ultra-rare liver conditions that previously had no approved therapies. The drug could become the first FDA-approved treatment for biliary atresia, a life-threatening condition affecting babies and children.
Scientists developed a treatment that switches off hepatitis B virus genes without cutting DNA, keeping 90% of treated mice virus-free for at least six months. The first human patient received the experimental therapy this year in an ongoing clinical trial.
Researchers discovered a protective enzyme that could prevent fatty liver disease from progressing to serious damage. The breakthrough offers hope for 100 million Americans living with the condition.
Children with a rare genetic liver disorder that causes severe itching and liver damage finally have a treatment option that addresses the root cause. After 20 years of research, Japan has approved a repurposed drug for progressive familial intrahepatic cholestasis types 1 and 2.
Children with a rare genetic liver disorder that often leads to transplant now have their first treatment to slow disease progression. After 20 years of research, Japanese doctors turned an existing drug into a life-changing option for young patients with PFIC.
China just approved Wegovy to treat severe fatty liver disease, giving hope to millions who previously had no effective medication. The breakthrough comes as one in three Chinese adults battles this often-silent condition.
Scientists are discovering that molecules from scorpion venom could become powerful new treatments for chronic liver disease and inflammation. After centuries of traditional use, researchers are now isolating specific peptides that target harmful immune responses without the toxic effects.
Scientists at McMaster University discovered a hormone that protects the liver from inflammation through a brain pathway, offering new hope for millions with advanced fatty liver disease. The breakthrough reveals the body's own defense system could inspire treatments that work even when weight loss doesn't help.
Artificial intelligence is helping doctors catch a silent epidemic affecting 1 billion people worldwide before it becomes deadly. Simple AI tools are turning routine medical tests into early warning systems for fatty liver disease.
Patients with severe liver disease can now get an implanted pump that automatically drains fluid buildup, eliminating painful weekly hospital visits. The first patient at Dartmouth Hitchcock hasn't needed a single drainage procedure since getting the device.
Thousands waiting for liver transplants may soon have another option: tiny functioning livers injected through a syringe. MIT researchers developed a groundbreaking technique that could save lives without major surgery.